Russell Investments Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-472
| Closed | -$16.9K | – | 3849 |
|
|
2024
Q4 | $16.9K | Buy |
472
+41
| +10% | +$2.12K | ﹤0.01% | 3043 |
|
|
2024
Q3 | $20.3K | Buy |
431
+50
| +13% | +$2.21K | ﹤0.01% | 2953 |
|
|
2024
Q2 | $19.1K | Buy |
381
+3
| +0.8% | +$217 | ﹤0.01% | 2945 |
|
|
2024
Q1 | $42.4K | Buy |
378
+343
| +980% | +$34.1K | ﹤0.01% | 2687 |
|
|
2023
Q4 | $2.04K | Hold |
35
| – | – | ﹤0.01% | 3009 |
|
|
2023
Q3 | $1.11K | Sell |
35
-3,956
| -99% | -$188K | ﹤0.01% | 3333 |
|
|
2023
Q2 | $328K | Buy |
3,991
+3,255
| +442% | +$476K | ﹤0.01% | 2351 |
|
|
2023
Q1 | $75.6K | Sell |
736
-200
| -21% | -$28.1K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $137K | Buy |
936
+80
| +9% | +$13.5K | ﹤0.01% | 2620 |
|
|
2022
Q3 | $144K | Buy |
856
+677
| +378% | +$110K | ﹤0.01% | 2613 |
|
|
2022
Q2 | $20K | Sell |
179
-2,079
| -92% | -$196K | ﹤0.01% | 2799 |
|
|
2022
Q1 | $224K | Buy |
+2,258
| New | +$264K | ﹤0.01% | 2437 |
|
|
2021
Q1 | – | Sell |
-268
| Closed | -$177K | – | 3167 |
|
|
2020
Q4 | $177K | Sell |
268
-431
| -62% | -$240K | ﹤0.01% | 2785 |
|
|
2020
Q3 | $325K | Sell |
699
-1,369
| -66% | -$692K | ﹤0.01% | 2580 |
|
|
2020
Q2 | $1.2M | Sell |
2,068
-1,621
| -44% | -$554K | ﹤0.01% | 1945 |
|
|
2020
Q1 | $541K | Buy |
+3,689
| New | +$645K | ﹤0.01% | 2139 |
|
|
2019
Q4 | – | Sell |
-723
| Closed | -$28K | – | 3113 |
|
|
2019
Q3 | $28K | Buy |
723
+167
| +30% | +$12.1K | ﹤0.01% | 2958 |
|
|
2019
Q2 | $56K | Buy |
556
+164
| +42% | +$19.3K | ﹤0.01% | 2718 |
|
|
2019
Q1 | $51K | Buy |
+392
| New | +$49.3K | ﹤0.01% | 2799 |
|
|
2018
Q3 | – | Sell |
-1,714
| Closed | -$766K | – | 2994 |
|
|
2018
Q2 | $766K | Hold |
1,714
| – | – | ﹤0.01% | 2255 |
|
|
2018
Q1 | $676K | Buy |
+1,714
| New | +$677K | ﹤0.01% | 2365 |
|
Other funds holding MRSN
NI
BCLSI
SSA
RSCM
VA
SCM
